Loading...
Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy
PURPOSE: Conventional therapies to treat prostate cancer (CaP) of androgen-dependent phenotype (ADPC) and castration resistant phenotype (CRPC) are deficient in outcome which has necessitated a need to identify agents those could target AR for both disease types. We provide mechanism-based evidence...
Na minha lista:
| Udgivet i: | Clin Cancer Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4573593/ https://ncbi.nlm.nih.gov/pubmed/21712449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0916 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|